About Qral Group
Qral Group is a Healthcare company based in New York (United States) founded in 2015. It provides consulting services for life sciences commercialization and business results. It operates on a B2B model in Healthcare and Business Services sectors. Its Indian entity Qral India Private Limited reported revenue of ₹30.20 Cr. Qral Group offers products and services including Management Consulting Services. Its focus areas include Life Sciences, Management Consulting, Commercialization and Rare Disease. Similar companies include Booz Allen Hamilton, Teneo and Cognizant; 1 of its 3 listed similar companies has raised funding.
Company details
Qral Group is a management consulting firm that connects experts to advance life sciences, focusing on rare disease, specialty, and mass market commercialization. They deliver end-to-end solutions across product life cycles, emphasizing trust and innovation. Operating from offices in New York, Chicago, San Francisco, Boston, and Delhi, they serve clients in the healthcare sector through strategic advice and intellectual challenges.
- Headquarters New York, United States
- SectorsHealthcareBusiness Services
- Phone•••• ••••
- Website qralgroup.com
- Social LinkedIn
- Legal Name Qral India Private Limited
- Date of Incorporation 20 Mar, 2017
- Jurisdiction Gurgaon, Haryana, India
- Indian entity revenue₹30.20 Cr
FY 2024 · +40% YoY
- Indian entity net profit₹4.77 Cr
FY 2024 · 16% margin
- Indian entity EBITDA₹6.60 Cr
FY 2024 · 22% margin
Associated legal entities of Qral Group
Qral Group operates through Qral India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Qral India Private Limited CIN U74999HR2017FTC068212 | Active | 20 Mar 2017 | Gurgaon, Haryana | ₹30.2 Cr | 3 | View details |
Products & Services of Qral Group
Qral Group offers a comprehensive portfolio of products and services, including Management Consulting Services.
Offers strategic advice for life sciences commercialization and business growth.
Board of directors of Qral India Private Limited (Qral Group)
Qral India Private Limited is the primary company behind Qral Group. The board of Qral India Private Limited currently have 3 directors; the longest-serving is Chih Kao Hu, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chih Kao Hu DIN 07683110 | Director | 20 Mar 2017 | 9 yrs 7 mo | Qral India Private Limited |
| Vasu Kamboj DIN 07669146 | Whole-time director | 20 Mar 2017 | 9 yrs 7 mo | Qral India Private Limited |
| Anuj Mangal DIN 08291815 | Whole-time director | 07 Dec 2018 | 7 yrs 11 mo | Qral India Private Limited |
People of Qral Group
8 people are tracked at Qral Group (2 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
| Founder of Qral Group | Leadership | |
Dimitra Georganopoulou | General Partner Qral Ventures | Leadership |
Jitendra Chouhan | Wordpress Developer | Team |
Alexandra Pritchard | Management Consultant | Team |
Deyri Garcia Mph | Recruiting Lead | Team |
Aarash Amani | Management Consultant | Team |
Clavan Dsouza | Management Consultant | Team |
Kavita Balhey | Management Consultant | Team |
Complete people profiles for Qral Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Qral Group
Figures of Qral India Private Limited, the primary company behind Qral Group, for FY 2024. Revenue was ₹30.20 Cr (+40% year on year). Net profit was ₹4.77 Cr (16% margin). EBITDA was ₹6.60 Cr (22% margin). Revenue has grown at a compounded annual rate of +38% over three years and +43% over five years.
- ₹30.20 CrRevenue · FY 2024 · +40% YoY
- ₹4.77 CrNet profit · 16% margin
- ₹6.60 CrEBITDA · 22% margin
- ₹10 LakhPaid-up capital
- +38%Revenue CAGR, 3 years
- +43%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Qral India Private Limited are on its company page.
Detailed financial statements for Qral Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Qral Group
Qral Group has 3 listed similar companies in our database, 1 of them funded. They include Booz Allen Hamilton, Teneo and Cognizant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| boozallen.com | 1914 | Mclean, United States | 34,200 | Analytics, cybersecurity, and digital transformation services are provided. | ||
| teneo.com | 2011 | New York, United States | $400M | 313 | Business consulting, financial advisory, and crisis management services are provided. | |
| cognizant.com | 1994 | United States | 14 | Provider of software development, cloud & data management, and IT consulting services |
Detailed similar companies of Qral Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Rare Diseases
3 companies that operate in the same segment as Qral Group (Rare Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Qral Group
Qral Group was founded in 2015.
Qral Group is headquartered in New York, United States. It is registered at New York, New York, United States.
The primary company behind Qral Group, Qral India Private Limited, reported revenue of ₹30.20 Cr for FY 2024, up 40% year on year.
Qral Group is a management consulting firm that connects experts to advance life sciences, focusing on rare disease, specialty, and mass market commercialization. They deliver end-to-end solutions across product life cycles, emphasizing trust and innovation. Operating from offices in New York, Chicago, San Francisco, Boston, and Delhi, they serve clients in the healthcare sector through strategic advice and intellectual challenges.
Qral Group's top competitors include Booz Allen Hamilton, Teneo and Cognizant.
Qral Group offers Management Consulting Services.
Qral Group operates through Qral India Private Limited.
The legal entities of Qral Group currently have 3 directors, including Chih Kao Hu, Vasu Kamboj, Anuj Mangal.